The FDA and the Loss of Gottlieb: What Does it Mean for Stem Cell Research?
Scott Gottlieb at his earlier Senate confirmation hearing
"Panic Attack" --That's what the headline this morning said about the resignation of Scott Gottlieb as head of the Food and Drug Administration(FDA).
The STAT article addressed the general biotech field and its worries. Gottlieb's departure, however, also creates some uncertainty involving Califor…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.